Know Cancer

forgot password

A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate

Phase 3
2 Years
Open (Enrolling)
Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor

Thank you

Trial Information

A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexate Followed by Consolidation With Stem Cell Rescue Versus the Same Therapy Without Methotrexate


I. Determine if treatment of pediatric patients with newly diagnosed supratentorial
primitive neuroectodermal CNS tumors or high-risk medulloblastoma with intensive induction
chemotherapy comprising vincristine, etoposide, cyclophosphamide, and cisplatin in
combination with high-dose methotrexate and leucovorin calcium followed by consolidation
chemotherapy comprising carboplatin and thiotepa and peripheral blood stem cell rescue
results in a higher complete response rate then in patients treated with the same regimen
without high-dose methotrexate and leucovorin calcium.


I. Determine whether biologic characterization of these tumors will refine therapeutic
stratification separating atypical teratoid rhabdoid tumors from primitive neuroectodermal
tumors (PNETs) and possibly identifying other markers of value for stratification within the
group of PNETs.

II. Compare event-free survival and patterns of failure in patients treated with these

III. Compare the acute, chronic, and late effects of these regimens, particularly in terms
of tolerance to the same consolidation regimen after treatment with 2 different induction
regimens, in these patients.

IV. Compare the gastrointestinal and nutritional toxicities of these regimens in these

V. Compare the quality of life outcomes in patients treated with these regimens.

VI. Compare the neuropsychological effects of these regimens in these patients.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
diagnosis* (M0 medulloblastoma with ≥ 1.5 cm² residual tumor vs M1 medulloblastoma [positive
lumbar CSF cytology] vs M2, M3, or M4 medulloblastoma vs supratentorial PNET [any M-stage]
vs M0 medulloblastoma < 8 months without residual disease or with < 1.5 cm² radiographic
measurable residual tumor vs anaplastic M0 medulloblastoma without residual disease or with
< 1.5 cm² radiographic measurable residual vs classic M0 (nondesmoplastic) medulloblastoma
with < 1.5 cm² radiographic measurable residual tumor).

NOTE: *All diagnoses are for children < 36 months unless otherwise noted.

INDUCTION THERAPY: Patients are randomized to 1 of 2 induction treatment arms.

ARM I: Patients receive vincristine IV on days 1, 8, and 15; etoposide IV over 1 hour on
days 1-3; cyclophosphamide IV over 1 hour on days 1 and 2; cisplatin IV over 6 hours on day
3; and filgrastim (G-CSF) IV or subcutaneously (SC) beginning on day 4 and continuing until
blood counts recover. Treatment repeats every 3 weeks for 3 courses in the absence of
disease progression or unacceptable toxicity.

ARM II: Patients receive vincristine IV on days 1, 8, and 15; high-dose methotrexate IV over
4 hours on day 1; and leucovorin calcium IV or orally every 6 hours beginning on day 2 and
continuing until methotrexate levels are in a safe range. Once methotrexate levels are in a
safe range, patients then receive etoposide IV over 1 hour on approximately days 4, 5, and
6, cyclophosphamide IV over 1 hour on approximately days 4 and 5, and cisplatin IV over 6
hours on approximately day 6. Patients also receive G-CSF IV or SC beginning 24 hours after
the completion of chemotherapy and continuing until blood counts recover. Treatment repeats
every 3 weeks for 3 courses in the absence of disease progression or unacceptable toxicity.

In both arms, patients with stable disease or partial response after induction therapy
proceed to second-look surgery followed by consolidation therapy. Patients with a complete
response after induction therapy proceed directly to consolidation therapy.

CONSOLIDATION THERAPY: Beginning no more than 6 weeks after completion of induction therapy,
patients receive consolidation therapy comprising carboplatin IV over 2 hours and thiotepa
IV over 2 hours on days 1 and 2 and G-CSF IV or SC beginning on day 54 and continuing until
blood counts recover. Patients also receive autologous peripheral blood stem cells (PBSC) IV
on day 4. Treatment repeats every 3 weeks for 3 courses in the absence of disease
progression or unacceptable toxicity.

Blood and tissue samples are collected at baseline for correlative studies, including gene
expression profiling, biological marker analysis (i.e., cMyc, ErbB2/ErbB4), comparative
genome analysis, and mutation analysis.

After completion of study therapy, patients are followed up periodically for 4 years and
then annually thereafter.

Inclusion Criteria:

- Diagnosis of 1 of the following:

- High-risk medulloblastoma defined by any of the following:

- Residual disease > 1.5 cm²

- Lumbar cerebral spinal fluid cytology positive for tumor cells by analysis
of fluid collected either before definitive surgery or ≥ 10 days after
definitive surgery unless contraindicated

- M0 disease in children < 8 months of age at diagnosis

- M2 or M3 metastatic disease by MRI

- M4 disease

- Supratentorial primitive neuroectodermal tumor (PNET)(any M-stage)

- Anaplastic medulloblastoma regardless of M-stage or residual tumor

- M0 classic, non-desmoplastic medulloblastoma (R1) with radiographically
measurable residual disease < 1.5 cm^2

- MRI evidence of spinal disease

- Tumor must be negative for INI1 gene

- Has undergone definitive surgery within the past 31 days

- No atypical teratoid rhabdoid tumors

- Biological specimens must be available for correlative laboratory studies

- Life expectancy > 8 weeks

- Creatinine clearance or radioisotope glomerular filtration rate ≥ 60 mL/min

- Bilirubin ≤ 1.5 times upper limit of normal (ULN)

- AST and ALT < 2 times ULN

- Shortening fraction ≥ 27% by echocardiogram

- Ejection fraction ≥ 47% by radionuclide angiogram

- No evidence of dyspnea at rest

- Pulse oximetry > 94% on room air

- Absolute neutrophil count > 1,000/mm³

- Platelet count > 100,000/mm³ (transfusion independent)

- Hemoglobin > 8 g/dL (RBC transfusions allowed)

- Prior corticosteroids allowed

- No prior radiation therapy or chemotherapy

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Complete response (CR) rate

Outcome Description:

The analysis of response will be based on a one-sided, two-sample test of proportions, with Type I error of 10%. Tumor response criteria are determined by changes in size using all 3 dimensional measurements: width (W), transverse (T), and length (L) measurements.

Outcome Time Frame:

From baseline to up to 4 years

Safety Issue:


Principal Investigator

Claire Mazewski

Investigator Role:

Principal Investigator

Investigator Affiliation:

Children's Oncology Group


United States: Food and Drug Administration

Study ID:




Start Date:

August 2007

Completion Date:

Related Keywords:

  • Untreated Childhood Medulloblastoma
  • Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
  • Medulloblastoma
  • Neuroectodermal Tumors
  • Neuroectodermal Tumors, Primitive



Baylor College of Medicine Houston, Texas  77030
Johns Hopkins University Baltimore, Maryland  21205
Memorial Sloan Kettering Cancer Center New York, New York  10021
Cleveland Clinic Foundation Cleveland, Ohio  44195
Roswell Park Cancer Institute Buffalo, New York  14263
Mayo Clinic Rochester, Minnesota  55905
Children's Hospital of Philadelphia Philadelphia, Pennsylvania  19104
University of Iowa Hospitals and Clinics Iowa City, Iowa  52242
University of Mississippi Medical Center Jackson, Mississippi  39216-4505
Washington University School of Medicine Saint Louis, Missouri  63110
Medical University of South Carolina Charleston, South Carolina  29425-0721
Medical City Dallas Hospital Dallas, Texas  75230
University of Texas Health Science Center at San Antonio San Antonio, Texas  78284-7811
Midwest Children's Cancer Center Milwaukee, Wisconsin  53226
Bronson Methodist Hospital Kalamazoo, Michigan  49007
Geisinger Medical Center Danville, Pennsylvania  17822-0001
Vanderbilt-Ingram Cancer Center Nashville, Tennessee  37232-6838
Loyola University Medical Center Maywood, Illinois  60153
Morristown Memorial Hospital Morristown, New Jersey  07962-1956
Marshfield Clinic Marshfield, Wisconsin  54449
Loma Linda University Medical Center Loma Linda, California  92354
Newark Beth Israel Medical Center Newark, New Jersey  07112
New York Medical College Valhalla, New York  10595
Dana-Farber Cancer Institute Boston, Massachusetts  02115
Cedars-Sinai Medical Center Los Angeles, California  90048
University of Arkansas for Medical Sciences Little Rock, Arkansas  72205
Eastern Maine Medical Center Bangor, Maine  04401
Hackensack University Medical Center Hackensack, New Jersey  07601
Children's Hospital Los Angeles Los Angeles, California  90027-0700
Children's National Medical Center Washington, District of Columbia  20010-2970
Miami Children's Hospital Miami, Florida  33155-4069
All Children's Hospital St. Petersburg, Florida  33701
Advocate Hope Children's Hospital Oak Lawn, Illinois  60453
Carolinas Medical Center Charlotte, North Carolina  28232-2861
University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma  73104
Legacy Emanuel Hospital and Health Center Portland, Oregon  97227
Driscoll Children's Hospital Corpus Christi, Texas  78466
Southern California Permanente Medical Group Downey, California  90242
Children's Hospital Central California Madera, California  93638-8762
Kosair Children's Hospital Louisville, Kentucky  40202-3830
Covenant Children's Hospital Lubbock, Texas  79410
Overlook Hospital Summit, New Jersey  07902-0220
Winthrop University Hospital Mineola, New York  11501
Cincinnati Children's Hospital Medical Center Cincinnati, Ohio  45229-3039
Methodist Children's Hospital of South Texas San Antonio, Texas  78229-3993
Primary Children's Medical Center Salt Lake City, Utah  84113-1100
Montefiore Medical Center Bronx, New York  10467-2490
Rady Children's Hospital - San Diego San Diego, California  92123-4282
Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota  55404
University of New Mexico Cancer Center Albuquerque, New Mexico  87131-5636
Nationwide Children's Hospital Columbus, Ohio  43205-2696
Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania  15213
Mary Bridge Children's Hospital and Health Center Tacoma, Washington  98415-0299
Presbyterian Hospital Charlotte, North Carolina  28233-3549
Lee Memorial Health System Fort Myers, Florida  33902
University of Alabama at Birmingham Birmingham, Alabama  35294-3300
Children's Hospital of Alabama Birmingham, Alabama  35233
Connecticut Children's Medical Center Hartford, Connecticut  06106
University of North Carolina Chapel Hill, North Carolina  27599
University of Florida Gainesville, Florida  32610-0277
University of Rochester Rochester, New York  14642
Nemours Children's Clinic - Pensacola Pensacola, Florida  32504
Helen DeVos Children's Hospital at Spectrum Health Grand Rapids, Michigan  49503
Mercy Children's Hospital Toledo, Ohio  43608
Legacy Emanuel Children's Hospital Portland, Oregon  97227
BI-LO Charities Children's Cancer Center Greenville, South Carolina  29605
University Of Vermont Burlington,, Vermont  05403
University of Kentucky Lexington, Kentucky  40536-0098
UC Davis Comprehensive Cancer Center Sacramento, California  95817
Oregon Health and Science University Portland, Oregon  97201
Tulane University Health Sciences Center New Orleans, Louisiana  70112
Virginia Commonwealth University Richmond, Virginia  
Florida Hospital Orlando, Florida  32803
Memorial Health University Medical Center Savannah, Georgia  31404
Seattle Children's Hospital Seattle, Washington  98105
Childrens Memorial Hospital Chicago, Illinois  60614
Sutter General Hospital Sacramento, California  95816
M D Anderson Cancer Center- Orlando Orlando, Florida  32806
University of Hawaii Honolulu, Hawaii  96813
Saint Luke's Mountain States Tumor Institute Boise, Idaho  83712
Saint Vincent Hospital and Health Services Indianapolis, Indiana  46260
Michigan State University - Breslin Cancer Center East Lansing, Michigan  48824-1313
Kalamazoo Center for Medical Studies Kalamazoo, Michigan  49008
Saint John's Mercy Medical Center Saint Louis, Missouri  63141
Nevada Cancer Research Foundation CCOP Las Vegas, Nevada  89106
New York University Langone Medical Center New York, New York  10016
Columbia University Medical Center New York, New York  10032
Cook Children's Medical Center Fort Worth, Texas  76104
Memorial Healthcare System - Joe DiMaggio Children's Hospital Hollywood, Florida  33021
The Children's Medical Center of Dayton Dayton, Ohio  45404
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida  33136
University of Minnesota Medical Center-Fairview Minneapolis, Minnesota  55455
C S Mott Children's Hospital Ann Arbor, Michigan  48109
Walter Reed National Military Medical Center Bethesda, Maryland  20889
UMDNJ - Robert Wood Johnson University Hospital New Brunswick, New Jersey  08903
Phoenix Childrens Hospital Phoenix, Arizona  85016
Miller Children's Hospital Long Beach, California  90806
Childrens Hospital of Orange County Orange, California  92868-3874
Alfred I duPont Hospital for Children Wilmington, Delaware  19803
Nemours Children's Clinic - Jacksonville Jacksonville, Florida  32207-8426
Nemours Childrens Clinic - Orlando Orlando, Florida  32806
Saint Joseph Children's Hospital of Tampa Tampa, Florida  33607
Children's Healthcare of Atlanta - Egleston Atlanta, Georgia  30322
The Childrens Mercy Hospital Kansas City, Missouri  64108
Rainbow Babies and Childrens Hospital Cleveland, Ohio  44106
Palmetto Health Richland Columbia, South Carolina  29203
East Tennessee Childrens Hospital Knoxville, Tennessee  37916
Saint Mary's Hospital West Palm Beach, Florida  33407
Saint Joseph's Regional Medical Center Paterson, New Jersey  07503
Texas Tech University Health Science Center-Amarillo Amarillo, Texas  79106
Children's Hospital Colorado Aurora, Colorado  80045
Floating Hospital for Children at Tufts Medical Center Boston, Massachusetts  02111
University of California San Francisco Medical Center-Parnassus San Francisco, California  94143
The Toledo Hospital/Toledo Children's Hospital Toledo, Ohio  43606
Saint Christopher's Hospital for Children Philadelphia, Pennsylvania  19134
Greenville Cancer Treatment Center Greenville, South Carolina  29605
Sanford USD Medical Center - Sioux Falls Sioux Falls, South Dakota  57117-5134
Providence Sacred Heart Medical Center and Children's Hospital Spokane, Washington  99204
Broward Health Medical Center Fort Lauderdale, Florida  33316